Palmoplantar psoriasis: a paradoxical adverse reaction induced by adalimumab.
Bordel-Gómez
M T
MT
Sánchez-Estella
J
J
Martínez-González
O
O
Cardeñoso-Alvarez
Maria E
ME
D000068879:Adalimumab; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D005260:Female; D005528:Foot; D006225:Hand; D006801:Humans; D008875:Middle Aged; D011565:Psoriasis / Q000139:chemically induced*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D014409:Tumor Necrosis Factor-alpha; D000068879:Adalimumab